Changes in Beneficial Ownership · 4

Immunovant, Inc.

IMVTNASDAQEQUITYCurrent

Changes in Beneficial Ownership

Filed Oct 23, 2026Accepted Oct 23, 2026, 4:55 PM EDTFiling CIK 1764013Accession 0001764013-26-000114

wk-form4_1792788920.xml

Name: Stout Jay S
Reporting owner CIK: 0001702969
Relationship: Officer
Officer title: Chief Technology Officer
Address: C/O IMMUNOVANT, INC., 1000 PARK FORTY PLAZA, SUITE 210, DURHAM, NC, 27713

Non-derivative transactions · 1 reported row
Security	Transaction date	Code	Amount	A / D	Price (USD)	Owned after	Ownership
Common Stock	2026-10-21	S · Form 4	2,595^[F1]	D	28.94^[F2]	198,937	D

Table key

F1: On April 17, 2023, the holder was granted 100,000 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on April 19, 2023, of which 6,250 of these RSUs vested on October 17, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.↩ 1
F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.31 - $29.15 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.↩ 1

Historical securities (2)